Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Ghostwriting in biomedicine: a review of the published literature.

DeTora LM, Carey MA, Toroser D, Baum EZ.

Curr Med Res Opin. 2019 May 22:1-9. doi: 10.1080/03007995.2019.1608101. [Epub ahead of print]

PMID:
30986084
2.

Prospective dose selection and acceleration of paliperidone palmitate 3-month formulation development using a pharmacometric bridging strategy.

Samtani MN, Nandy P, Ravenstijn P, Remmerie B, Vermeulen A, Russu A, D'hoore P, Baum EZ, Savitz A, Gopal S, Hough D.

Br J Clin Pharmacol. 2016 Nov;82(5):1364-1370. doi: 10.1111/bcp.13050. Epub 2016 Jul 24.

3.

Angiogenic properties of human placenta-derived adherent cells and efficacy in hindlimb ischemia.

Francki A, Labazzo K, He S, Baum EZ, Abbot SE, Herzberg U, Hofgartner W, Hariri R; Celgene Cellular Therapeutics Research Group.

J Vasc Surg. 2016 Sep;64(3):746-756.e1. doi: 10.1016/j.jvs.2015.04.387. Epub 2015 Jun 6.

4.

Human placenta-derived adherent cells improve cardiac performance in mice with chronic heart failure.

Chen HJ, Chen CH, Chang MY, Tsai DC, Baum EZ, Hariri R, Herzberg U, Hsieh PC.

Stem Cells Transl Med. 2015 Mar;4(3):269-75. doi: 10.5966/sctm.2014-0135. Epub 2015 Feb 11.

5.

Antistaphylococcal activities of the new fluoroquinolone JNJ-Q2.

Morrow BJ, Abbanat D, Baum EZ, Crespo-Carbone SM, Davies TA, He W, Shang W, Queenan AM, Lynch AS.

Antimicrob Agents Chemother. 2011 Dec;55(12):5512-21. doi: 10.1128/AAC.00470-11. Epub 2011 Sep 12.

6.

MurF inhibitors with antibacterial activity: effect on muropeptide levels.

Baum EZ, Crespo-Carbone SM, Foleno BD, Simon LD, Guillemont J, Macielag M, Bush K.

Antimicrob Agents Chemother. 2009 Aug;53(8):3240-7. doi: 10.1128/AAC.00166-09. Epub 2009 May 26.

7.

Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.

Baum EZ, Crespo-Carbone SM, Morrow BJ, Davies TA, Foleno BD, He W, Queenan AM, Bush K.

Antimicrob Agents Chemother. 2009 Jul;53(7):2785-90. doi: 10.1128/AAC.00018-09. Epub 2009 May 11.

8.

A MurF inhibitor that disrupts cell wall biosynthesis in Escherichia coli.

Baum EZ, Crespo-Carbone SM, Klinger A, Foleno BD, Turchi I, Macielag M, Bush K.

Antimicrob Agents Chemother. 2007 Dec;51(12):4420-6. Epub 2007 Oct 1.

9.

Utility of muropeptide ligase for identification of inhibitors of the cell wall biosynthesis enzyme MurF.

Baum EZ, Crespo-Carbone SM, Abbanat D, Foleno B, Maden A, Goldschmidt R, Bush K.

Antimicrob Agents Chemother. 2006 Jan;50(1):230-6.

10.

Identification of a dithiazoline inhibitor of Escherichia coli L,D-carboxypeptidase A.

Baum EZ, Crespo-Carbone SM, Foleno B, Peng S, Hilliard JJ, Abbanat D, Goldschmidt R, Bush K.

Antimicrob Agents Chemother. 2005 Nov;49(11):4500-7.

11.

Synthesis and antibacterial activity of C-6 carbamate ketolides, a novel series of orally active ketolide antibiotics.

Henninger TC, Xu X, Abbanat D, Baum EZ, Foleno BD, Hilliard JJ, Bush K, Hlasta DJ, Macielag MJ.

Bioorg Med Chem Lett. 2004 Sep 6;14(17):4495-9.

PMID:
15357979
12.

Pyrimido[1,2-b]-1,2,4,5-tetrazin-6-ones as HCMV protease inhibitors: a new class of heterocycles with flavin-like redox properties.

Di Grandi MJ, Curran KJ, Baum EZ, Bebernitz G, Ellestad GA, Ding WD, Lang SA, Rossi M, Bloom JD.

Bioorg Med Chem Lett. 2003 Oct 20;13(20):3483-6.

PMID:
14505653
13.

A point mutation in influenza B neuraminidase confers resistance to peramivir and loss of slow binding.

Baum EZ, Wagaman PC, Ly L, Turchi I, Le J, Bucher D, Bush K.

Antiviral Res. 2003 Jun;59(1):13-22.

PMID:
12834856
14.

Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.

Smee DF, Sidwell RW, Morrison AC, Bailey KW, Baum EZ, Ly L, Wagaman PC.

Antiviral Res. 2001 Dec;52(3):251-9.

PMID:
11675142
15.

Identification and characterization of new inhibitors of the Escherichia coli MurA enzyme.

Baum EZ, Montenegro DA, Licata L, Turchi I, Webb GC, Foleno BD, Bush K.

Antimicrob Agents Chemother. 2001 Nov;45(11):3182-8.

16.

The synthesis and SAR of rhodanines as novel class C beta-lactamase inhibitors.

Grant EB, Guiadeen D, Baum EZ, Foleno BD, Jin H, Montenegro DA, Nelson EA, Bush K, Hlasta DJ.

Bioorg Med Chem Lett. 2000 Oct 2;10(19):2179-82.

PMID:
11012024
17.

Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems.

Hilliard JJ, Goldschmidt RM, Licata L, Baum EZ, Bush K.

Antimicrob Agents Chemother. 1999 Jul;43(7):1693-9.

19.

The human cytomegalovirus UL97 protein is phosphorylated and a component of virions.

van Zeijl M, Fairhurst J, Baum EZ, Sun L, Jones TR.

Virology. 1997 Apr 28;231(1):72-80.

20.

Development of a scintillation proximity assay for human cytomegalovirus protease using 33phosphorous.

Baum EZ, Johnston SH, Bebernitz GA, Gluzman Y.

Anal Biochem. 1996 May 15;237(1):129-34.

PMID:
8660547
21.

Flavins inhibit human cytomegalovirus UL80 protease via disulfide bond formation.

Baum EZ, Ding WD, Siegel MM, Hulmes J, Bebernitz GA, Sridharan L, Tabei K, Krishnamurthy G, Carofiglio T, Groves JT, Bloom JD, DiGrandi M, Bradley M, Ellestad G, Seddon AP, Gluzman Y.

Biochemistry. 1996 May 7;35(18):5847-55.

PMID:
8639546
22.

Inhibition of human cytomegalovirus UL80 protease by specific intramolecular disulfide bond formation.

Baum EZ, Siegel MM, Bebernitz GA, Hulmes JD, Sridharan L, Sun L, Tabei K, Johnston SH, Wildey MJ, Nygaard J, Jones TR, Gluzman Y.

Biochemistry. 1996 May 7;35(18):5838-46.

PMID:
8639545
23.

Proteolytic activity of human cytomegalovirus UL80 protease cleavage site mutants.

Jones TR, Sun L, Bebernitz GA, Muzithras VP, Kim HJ, Johnston SH, Baum EZ.

J Virol. 1994 Jun;68(6):3742-52.

24.

Expression and analysis of the human cytomegalovirus UL80-encoded protease: identification of autoproteolytic sites.

Baum EZ, Bebernitz GA, Hulmes JD, Muzithras VP, Jones TR, Gluzman Y.

J Virol. 1993 Jan;67(1):497-506.

25.

Purification, properties, and mutagenesis of poliovirus 3C protease.

Baum EZ, Bebernitz GA, Palant O, Mueller T, Plotch SJ.

Virology. 1991 Nov;185(1):140-50.

PMID:
1656583
27.
28.

K-ras oncogene expression in Xenopus laevis.

Baum EZ, Bebernitz GA.

Oncogene. 1990 May;5(5):763-7.

PMID:
2189109
29.
30.

Post-translational control of ribosomal protein L1 accumulation in Xenopus oocytes.

Baum EZ, Hyman LE, Wormington WM.

Dev Biol. 1988 Mar;126(1):141-9.

PMID:
3342930
31.

Temporally regulated tandem promoters in Micromonospora echinospora.

Baum EZ, Love SF, Rothstein DM.

J Bacteriol. 1988 Jan;170(1):71-7.

32.

Coordinate expression of ribosomal protein genes during Xenopus development.

Baum EZ, Wormington WM.

Dev Biol. 1985 Oct;111(2):488-98.

PMID:
3840103
33.

Inhibition of protein synthesis in reticulocyte lysates by a double-stranded RNA component in HeLa mRNA.

Baum EZ, Ernst VG.

Biochem Biophys Res Commun. 1983 Jul 18;114(1):41-9.

PMID:
6882432

Supplemental Content

Support Center